Position in ALT
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$172,498
+$45,145 QoQ
Shares Held
56,743
+72.4% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#94
of 210 holders
Holding Since
Sep 2021
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ENVESTNET ASSET MANAGEMENT INC holds $901,256,539 across 108 Biotechnology names. ALT ranks #99 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
487,627 | $242,218,959 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
109,838 | $68,488,386 | |
| 3 | EXEL |
Exelixis, Inc.
|
949,669 | $51,671,490 | |
| 4 | ARGX |
Argenx SE
|
55,346 | $51,348,358 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
136,395 | $41,058,986 | |
| 6 | INSM |
INSMED Inc
|
336,997 | $35,930,620 | |
| 7 | RPRX |
Royalty Pharma plc
|
513,096 | $28,769,292 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
713,946 | $25,266,548 |
All Filings in ALT
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $172,498 | 56,743 | Shares | Sole | 2026-08-03 | |
| 2025-06-30 | $127,353 | 32,908 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $111,185 | 22,237 | Shares | Sole | 2025-04-29 | |
| 2024-09-30 | $117,175 | 19,084 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $184,976 | 27,816 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $371,905 | 36,533 | Shares | Sole | 2024-05-13 | |
| 2023-06-30 | $109,380 | 30,986 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $97,068 | 23,002 | Shares | Sole | 2023-05-11 | |
| 2021-09-30 | $171,550 | 15,168 | Shares | Sole | 2021-10-07 | |
| No filing history on record for this holder in this stock. | ||||||